Financials

News Ideas Discussions Technicals Seasonals

MGRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Mangoceuticals, Inc. operating, investing, and financing activities

MGRX free cash flow for Q3 24 is -1.17 M USD. For 2023, MGRX free cash flow was -7 M USD and operating cash flow was -7 M USD.

Q2 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—